XLO · Company research
Xilio Therapeutics, Inc. (XLO): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
19records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| (XLO) Volatility Zones as Tactical Triggers - Stock Traders Daily | (XLO) Volatility Zones as Tactical Triggers Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 19, 2026 | neutral | 0 | 0.6 |
| Trading Systems Reacting to (XLO) Volatility - Stock Traders Daily | Trading Systems Reacting to (XLO) Volatility Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 8, 2026 | neutral | 0 | 0.6 |
| Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Xilio Therapeutics granted stock options to new employees and newly appointed Chief Medical Officer Yariv Houvras, M.D., Ph.D. on October 1, 2026. The company granted 100,895 shares to two new employees and 105,000 shares to Dr. Houvras at an exercise price of $8.91 per share, with a standard vesting schedule of 25% after one year followed by 36 monthly installments. | View source ↗ | GlobeNewswire Inc. | Oct 2, 2026 | neutral | 0 | 1 |
| A new medical chief gets options to buy 105,000 Xilio shares at $8.91 each. - Stock Titan | A new medical chief gets options to buy 105,000 Xilio shares at $8.91 each. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| Xilio's new medical chief brings over 20 years in medicine and research - Stock Titan | Xilio's new medical chief brings over 20 years in medicine and research Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| XLO Form 4 Filings - Xilio Therapeutics, Inc. SEC Form 4 - Stock Titan | XLO Form 4 Filings - Xilio Therapeutics, Inc. SEC Form 4 Stock Titan | View source ↗ | Stock Titan | Sep 25, 2026 | neutral | 0 | 0.6 |
| Two new hires get options on 19,865 Xilio shares - Stock Titan | Two new hires get options on 19,865 Xilio shares Stock Titan | View source ↗ | Stock Titan | Sep 2, 2026 | neutral | 0 | 0.6 |
| Weekly Recap: Xilio (XLO) Q2 revenue jump and FDA IND cleared for XTX501 - TradingView | Weekly Recap: Xilio (XLO) Q2 revenue jump and FDA IND cleared for XTX501 TradingView | View source ↗ | TradingView | Aug 17, 2026 | neutral | 0 | 0.6 |
| Xilio Therapeutics Reports $18.7 Million Q2 Revenue and FDA Clearance for XTX501 - Quiver Quantitative | Xilio Therapeutics Reports $18.7 Million Q2 Revenue and FDA Clearance for XTX501 Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 12, 2026 | neutral | 0 | 0.6 |
| Xilio Therapeutics (XLO) Holds Steady at $9.18 as Biotech Stock Consolidates Near Support - High Conviction Picks - www.dars.gov.et | Xilio Therapeutics (XLO) Holds Steady at $9.18 as Biotech Stock Consolidates Near Support - High Conviction Picks www.dars.gov.et | View source ↗ | www.dars.gov.et | Aug 11, 2026 | neutral | 0 | 0.6 |
| Xilio Therapeutics (XLO) Holds Steady Near Resistance – Biotech Stock in Tight Range - Triple MA Cross - dars.gov.et | Xilio Therapeutics (XLO) Holds Steady Near Resistance – Biotech Stock in Tight Range - Triple MA Cross dars.gov.et | View source ↗ | dars.gov.et | Jul 17, 2026 | neutral | 0 | 0.6 |
| Xilio Therapeutics (XLO) Holds Steady Near Resistance – Biotech Stock in Tight Range - Institutional Buy Signals - www.dars.gov.et | Xilio Therapeutics (XLO) Holds Steady Near Resistance – Biotech Stock in Tight Range - Institutional Buy Signals www.dars.gov.et | View source ↗ | www.dars.gov.et | Jul 17, 2026 | neutral | 0 | 0.6 |
| Xilio Therapeutics, Inc. (XLO) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance | Xilio Therapeutics, Inc. (XLO) Reports Q1 Loss, Beats Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | May 12, 2026 | neutral | 0 | 0.6 |
| Xilio Therapeutics Inc. (XLO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade | Xilio Therapeutics Inc. (XLO) Stock Price | Live Quotes & Charts | NASDAQ StocksToTrade | View source ↗ | StocksToTrade | Apr 12, 2026 | neutral | 0 | 0.6 |
| Xilio Therapeutics (XLO) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance | Xilio Therapeutics (XLO) Upgraded to Buy: What Does It Mean for the Stock? Yahoo Finance | View source ↗ | Yahoo Finance | Apr 1, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Mar 27, 2024 | neutral | 0 | 0.6 |
| What is the current Price Target and Forecast for Xilio Therapeutics (XLO) - Zacks Investment Research | What is the current Price Target and Forecast for Xilio Therapeutics (XLO) Zacks Investment Research | View source ↗ | Zacks Investment Research | Nov 8, 2022 | neutral | 0 | 0.6 |
| Xilio Therapeutics, Inc. (XLO) Stock Price, News, Quote & History - Yahoo! Finance Canada | Xilio Therapeutics, Inc. (XLO) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Nov 3, 2021 | neutral | 0 | 0.6 |
| XLO Stock Price and Chart — NASDAQ:XLO - TradingView | XLO Stock Price and Chart — NASDAQ:XLO TradingView | View source ↗ | TradingView | Nov 1, 2021 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.